Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs

We read with interest the publication on malaria treatment by Obonyo et al. (Malaria J 21:30, 2022). This commentary questions the methodology, especially the chosen time points of treatment outcome measures.

Detalles Bibliográficos
Autores principales: Krishna, Sanjeev, Kremsner, Peter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208120/
https://www.ncbi.nlm.nih.gov/pubmed/35725411
http://dx.doi.org/10.1186/s12936-022-04170-1
_version_ 1784729672835137536
author Krishna, Sanjeev
Kremsner, Peter G.
author_facet Krishna, Sanjeev
Kremsner, Peter G.
author_sort Krishna, Sanjeev
collection PubMed
description We read with interest the publication on malaria treatment by Obonyo et al. (Malaria J 21:30, 2022). This commentary questions the methodology, especially the chosen time points of treatment outcome measures.
format Online
Article
Text
id pubmed-9208120
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92081202022-06-21 Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs Krishna, Sanjeev Kremsner, Peter G. Malar J Comment We read with interest the publication on malaria treatment by Obonyo et al. (Malaria J 21:30, 2022). This commentary questions the methodology, especially the chosen time points of treatment outcome measures. BioMed Central 2022-06-20 /pmc/articles/PMC9208120/ /pubmed/35725411 http://dx.doi.org/10.1186/s12936-022-04170-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Comment
Krishna, Sanjeev
Kremsner, Peter G.
Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs
title Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs
title_full Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs
title_fullStr Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs
title_full_unstemmed Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs
title_short Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs
title_sort need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208120/
https://www.ncbi.nlm.nih.gov/pubmed/35725411
http://dx.doi.org/10.1186/s12936-022-04170-1
work_keys_str_mv AT krishnasanjeev needforoptimizeddosagesinthedesignofcomparativeclinicaltrialsofantimalarialdrugs
AT kremsnerpeterg needforoptimizeddosagesinthedesignofcomparativeclinicaltrialsofantimalarialdrugs

Ejemplares similares